Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's delve into Pfizer Inc ...

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look.

Pfizer's 7.5% dividend yield is safe due to revenue growth, cost efficiency, and a stronger balance sheet, making it a strong buy. Pfizer's innovation in R&D, including AI partnerships and new ...

Pfizer's stock ... offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker than pre-pandemic levels, and valuation analysis shows the stock ...

Consider pharmaceutical giant Pfizer (NYSE: PFE). Its dividend yield is around 7.5% right now, and if the stock continues to decline, it may not be long before it hits 8%. The big question is ...

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

InvestingPro data shows the stock is currently undervalued compared to its Fair Value estimate, with a P/E ratio of 17.99 and an attractive dividend yield ... detailed analysis about Pfizer's ...